Back to Acceleration Radar
CDRECadre Holdings Inc
Health Care · Industrial Specialties · Small
$29.99+1.80%
As of 23 Oct 2026Mkt cap $1.2B
Stage 13
AVOID
Fundamentals
39.8/75
Technical
4.7/15
Independent
44.5/90
GCAE viewstructural technical damage is a hard non-actionable condition
Price
- 1M
- +14.4%
- 3M
- −8.6%
- 6M
- +1.8%
- 1Y
- −27.0%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 37.0xHist median 37.1x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 16.7x
- FCF yield
- 6.0%
Quality
- ROIC
- 10.1%
- Operating margin
- 11.7%
- FCF margin
- 9.3%
- Current ratio
- 3.5x
Growth
- Revenue growth
- +7.5%Latest FY YoY
- Revenue CAGR
- +9.3%
- EPS CAGR
- +23.4%
- FCF CAGR
- +11.1%
Capital
- Share-count trend
- +7.0%3Y annualised
- Net debt
- $205M3.2x OCF
Annual trend
- CAGR 2021–2025
- +9.3%
- Latest · 2025
- $1B
- YoY
- +7.5%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
structural technical damage is a hard non-actionable condition
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-04
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- damaged
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded